KFDA picks 40 active ingredients to prevent concomitant administration

The Korea Food and Drug Administration said Friday it has additionally selected 40 medical ingredients which should not be mixed with others, or has safety problems and age limitations.

If doctors still want to prescribe the medicine, the contents must be described in the prescription and patients informed in advance, the KFDA said.

So far, the drug agency designated 474 drug substances t...